HCM HUTCHMED (China) Limited - American Depositary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 5, 2026
$14.20
· of 52w range
· above low
· to high
$9.7752w low
$16.4052w high
Market Cap
$12.39B
P/E
27.3
EPS
$0.52
Revenue
$549M
your badges
52W Range
$10–$16
Analyst Rating
BUY
Price Target
$22
P/E
27.3
ROE
45.7%
Net Profit Margin
83.3%
Your badge strip is empty — pin a metric anywhere on this page.
HCM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$14.20
Market Cap
$12.39B
P/E
27.3
EPS
$0.52
Revenue
$549M
ROE
45.7%
Debt/Equity
0.1
52W Range
$10–$16
HCM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$549M2016-12-31 → 2025-12-31
EPS$0.522016-12-31 → 2025-12-31
Free Cash Flow$-79M2016-12-31 → 2025-12-31
Net margin83.3%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | HCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 27.35Y avg ≈72.4 | ≈72.4 | · | · | |
| P/S | 22.65Y avg ≈35.0 | ≈35.0 | · | · | |
| P/B | 10.05Y avg ≈19.8 | ≈19.8 | · | · | |
| EV / EBITDA | -430.85Y avg ≈-67.2 | ≈-67.2 | · | · | |
| Price / FCF | -157.25Y avg ≈-192.5 | ≈-192.5 | · | · | |
| Price / Cash Flow | -191.65Y avg ≈4993.4 | ≈4993.4 | · | · | |
| EV / Revenue | 20.35Y avg ≈33.3 | ≈33.3 | · | · | |
| EV / FCF | -141.35Y avg ≈-180.5 | ≈-180.5 | · | · | |
| Price / Tangible Book | 10.15Y avg ≈19.9 | ≈19.9 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | HCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -7.1%5Y avg ≈-39.9% | ≈-39.9% | · | · | |
| EBITDA Margin | -4.7%5Y avg ≈-38.1% | ≈-38.1% | · | · | |
| Pretax Margin | 90.9%5Y avg ≈-11.8% | ≈-11.8% | · | · | |
| Net Profit Margin | 83.3%5Y avg ≈-7.6% | ≈-7.6% | · | · | |
| ROA | 30.2%5Y avg ≈-1.3% | ≈-1.3% | · | · | |
| ROE | 45.7%5Y avg ≈-1.2% | ≈-1.2% | · | · | |
| ROIC | -2.5%5Y avg ≈-27.5% | ≈-27.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | HCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.15Y avg ≈0.1 | ≈0.1 | · | · | |
| Current Ratio | 5.05Y avg ≈3.4 | ≈3.4 | · | · | |
| Quick Ratio | 4.75Y avg ≈3.1 | ≈3.1 | · | · | |
| Long-Term Debt / Equity | 0.15Y avg ≈0.1 | ≈0.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | HCM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover | 7.3 | · | · | · | |
| Receivables Turnover | 3.95Y avg ≈5.3 | ≈5.3 | · | · | |
| Revenue / Employee | ≈$306.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
95.6%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2023 | $0.19 | $-0.38 | 149.9% | |
| Dec. 31, 2021 | $-0.26 | $-1.06 | 75.6% | |
| June 30, 2021 | $-0.14 | $-0.77 | 81.9% | |
| Dec. 31, 2020 | $-0.11 | $-0.44 | 75.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | $178M | $87M | |
| Cost of Revenue | $336M | $349M | $384M | $311M | · | · | · | · | $170M | $149M | $105M | $53M | |
| R&D Expense | $148M | $212M | $302M | $387M | $299M | $175M | $138M | $114M | $76M | $67M | $47M | $30M | |
| SG&A Expense | $67M | $64M | $80M | $92M | $89M | $50M | $39M | $31M | $24M | $22M | $20M | $13M | |
| Operating Expenses | $588M | $674M | $820M | $834M | $684M | $425M | $351M | $307M | $295M | $263M | $188M | $106M | |
| Operating Income | $-39M | $-44M | $18M | $-408M | $-328M | $-197M | $-146M | $-93M | $-53M | $-47M | $-10M | $-18M | |
| Interest Expense | · | · | $759.0K | $652.0K | $592.0K | $787.0K | $1M | $1M | $1M | $2M | $1M | $2M | |
| Interest Income | $50M | $40M | $36M | $10M | $2M | $3M | $5M | $6M | $1M | $502.0K | $451.0K | $559.0K | |
| Other Non-op | $61M | $43M | $40M | $-3M | $-9M | $7M | $5M | $6M | $-119.0K | $-659.0K | $-769.0K | $-761.0K | |
| Pretax Income | $499M | $-1M | $58M | $-410M | $-216M | $-190M | $-141M | $-87M | $-54M | $-47M | $-11M | $-3M | |
| Income Tax | $64M | $7M | $5M | $-283.0K | $12M | $5M | $3M | $4M | $3M | $4M | $2M | $1M | |
| Net Income | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | $8M | $-7M | |
| EPS (Basic) | $0.53 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-0.11 | $-0.04 | $0.20 | $-0.64 | $-0.62 | |
| EPS (Diluted) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | $-0.64 | $-0.62 | |
| Shares (Basic) | 858,276,608 | 855,351,683 | 849,654,296 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 664,263,820 | 617,171,710 | 59,715,173 | 54,659,315 | 52,563,387 | |
| Shares (Diluted) | 872,891,120 | 872,829,129 | 869,196,348 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 66,426,382 | 61,717,171 | 59,971,050 | 54,659,315 | 52,563,387 | |
| EBITDA | $-26M | $-31M | $27M | $-399M | $-321M | $-191M | $-141M | $-89M | $-51M | $-44M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $71M | $154M | $284M | $313M | $378M | $236M | $121M | $86M | $85M | $79M | $32M | $39M | |
| Short-term Investments | $1.30B | $682M | $603M | $318M | $634M | $200M | $96M | $215M | $273M | $24M | $0 | · | |
| Receivables | $127M | $156M | $117M | $98M | $84M | $48M | $41M | $40M | $38M | $41M | $33M | · | |
| Inventory | $41M | $50M | $50M | $57M | $36M | $20M | $16M | $12M | $12M | $13M | $10M | · | |
| Prepaid Expense | $8M | $8M | $7M | $22M | $14M | $7M | $4M | $4M | $3M | $699.0K | · | · | |
| Current Assets | $1.57B | $1.07B | $1.10B | $840M | $1.21B | $531M | $317M | $371M | $432M | $167M | $90M | · | |
| PP&E (Net) | $95M | $92M | $100M | $76M | $41M | $24M | $21M | $17M | $14M | $10M | $9M | · | |
| PP&E (Gross) | $168M | $152M | $146M | $113M | $74M | $50M | $44M | $36M | $32M | $24M | $22M | · | |
| Accum. Depreciation | · | · | · | $37M | $33M | $26M | $23M | $20M | $17M | $14M | $13M | $13M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $9M | · | $21.0K | $85.0K | $163.0K | $227.0K | $275.0K | $347.0K | $430.0K | $469.0K | $571.0K | · | |
| Other Non-current Assets | $20M | $12M | $15M | $16M | $22M | $20M | $6M | · | · | · | · | · | |
| Total Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Accounts Payable | $46M | $43M | $36M | $71M | $41M | $32M | $24M | $26M | $24M | $36M | $21M | · | |
| Short-term Debt | $25M | $23M | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $316M | $377M | $403M | $354M | $312M | $158M | $113M | $85M | $105M | $95M | $81M | · | |
| Capital Leases | $2M | $4M | $3M | $5M | $7M | $6M | $3M | · | · | · | · | · | |
| Deferred Tax | $255.0K | $3M | $1M | $3M | $3M | $5M | $3M | · | $4M | $4M | $3M | · | |
| Other Non-current Liabilities | · | $11M | $11M | $12M | $12M | $9M | $6M | $2M | $1M | $8M | $10M | · | |
| Total Liabilities | $502M | $502M | $536M | $393M | $333M | $205M | $152M | $120M | $113M | $138M | $127M | · | |
| Long-term Debt | $93M | $83M | $79M | $18M | · | · | · | $27M | $30M | $47M | $50M | · | |
| Total Debt | $118M | $106M | $110M | $18M | $27M | $27M | $27M | $27M | $30M | $27M | · | · | |
| Common Stock | $87M | $87M | $87M | $86M | $86M | $73M | $67M | $67M | $66M | $61M | $57M | · | |
| Retained Earnings | $-379M | $-833M | $-871M | $-971M | $-610M | $-416M | $-290M | $-183M | $-107M | $-80M | $-92M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $2M | $2M | · | |
| AOCI | $-5M | $-12M | $-8M | $-2M | $6M | $4M | $-4M | $-243.0K | $5M | $-4M | $5M | · | |
| Stockholders' Equity | $1.24B | $760M | $731M | $610M | $987M | $484M | $288M | $389M | $462M | $184M | $83M | · | |
| Liabilities + Equity | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Shares Outstanding | 872,328,000 | 871,601,000 | 871,256,000 | 864,775,000 | 864,531,000 | 727,722,000 | 666,906,000 | 666,577,000 | 664,470,000 | 607,058,000 | 56,533,000 | 53,076,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $8M | $9M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Deferred Tax | $-118.0K | $5M | $2M | $-4M | $-5M | $3M | $2M | $2M | $2M | $3M | $1M | · | |
| Other Non-cash | $-596M | $-117M | $179M | $146M | $20M | $84M | $35M | $44M | $-1M | $-24M | · | · | |
| Operating Cash Flow | $-65M | $497.0K | $219M | $-269M | $-204M | $-62M | $-81M | $-33M | $-9M | $-10M | $-9M | $8M | |
| CapEx | $14M | $18M | $33M | $37M | $16M | $8M | $9M | $6M | $5M | $4M | $3M | $4M | |
| Investing Cash Flow | $-29M | $-96M | $-291M | $297M | $-306M | $-125M | $119M | $44M | $-261M | $-34M | $9M | $-15M | |
| Stock Issued | $2M | $790.0K | $5M | $174.0K | $717M | $319M | $251.0K | $4M | $302M | $111M | $1M | $3M | |
| Stock Repurchased | · | $36M | $9M | $48M | $27M | $13M | $346.0K | $5M | $1M | $604.0K | $2M | · | |
| Net Stock Activity | $2M | $-35M | $-4M | $-48M | $690M | $306M | $-95.0K | $-2M | $300M | $110M | · | · | |
| Financing Cash Flow | $8M | $-31M | $49M | $-83M | $650M | $296M | $-1M | $-8M | $273M | $92M | $-5M | $-641.0K | |
| Net Change in Cash | $-83M | $-130M | $-30M | $-64M | $142M | $114M | $35M | $771.0K | $6M | $47M | $-7M | $-8M | |
| Taxes Paid | $62M | $4M | $4M | $19M | $5M | $6M | $3M | $4M | $4M | $3M | $510.0K | $-908.0K | |
| Free Cash Flow | $-79M | $-17M | $187M | $-305M | $-221M | $-70M | $-89M | $-39M | $-14M | $-14M | · | · | |
| Levered FCF | · | · | $186M | $-306M | $-221M | $-71M | $-91M | $-40M | $-16M | $-15M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% | -86.3% | -71.5% | -43.3% | -22.1% | -21.6% | · | · | |
| Net Margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.1% | -51.7% | -34.9% | -11.1% | 5.4% | · | · | |
| Pretax Margin | 90.9% | -0.18% | 7.0% | -96.2% | -60.6% | -83.2% | -68.9% | -40.5% | -22.2% | 9.5% | · | · | |
| EBITDA Margin | -4.7% | -5.0% | 3.2% | -93.6% | -90.2% | -83.6% | -69.0% | -41.6% | -21.1% | -20.5% | · | · | |
| ROA | 30.2% | 2.9% | 8.7% | -30.0% | -18.6% | -21.1% | -21.3% | -13.2% | -5.7% | 4.1% | · | · | |
| ROE | 45.7% | 5.1% | 15.0% | -45.2% | -26.5% | -32.6% | -31.3% | -17.6% | -8.3% | 8.7% | · | · | |
| ROIC | -2.5% | -37.8% | 2.0% | -64.8% | -34.2% | -39.5% | -47.6% | -23.3% | -11.5% | -17.4% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 | 3.4 | 2.8 | 4.3 | 4.1 | 1.8 | · | · | |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 | 3.0 | 2.3 | 4.0 | 3.8 | 1.5 | · | · | |
| Debt / Equity | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Interest Coverage | · | · | 24.2 | -625.3 | -554.6 | -249.9 | -142.1 | -91.8 | -36.7 | -28.6 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.5 | 0.7 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | · | · | |
| Inventory Turnover | 7.3 | 6.9 | · | · | · | · | · | · | 13.8 | 13.3 | · | · | |
| Receivables Turnover | 3.9 | 4.6 | 7.8 | 4.7 | 5.4 | 5.2 | 5.0 | 5.4 | 6.1 | 5.8 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $0.87 | $0.84 | $0.71 | $1.14 | $0.67 | $0.43 | $5.84 | $6.95 | $3.04 | · | · | |
| Revenue / Share | $0.63 | $0.72 | $0.96 | $0.50 | $0.45 | · | · | $3.22 | $3.91 | $3.60 | · | · | |
| Cash Flow / Share | $-0.07 | $0.00 | $0.25 | $-0.32 | $-0.26 | · | · | $-0.49 | $-0.14 | $-0.16 | · | · | |
| Cash / Share | $0.08 | $0.18 | $0.33 | $0.36 | $0.44 | $0.32 | $0.18 | $1.29 | $1.28 | $1.31 | · | · | |
| EPS (TTM) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | · | · | |
| Net Income TTM | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | · | · | |
| Market Cap | $11.63B | $12.56B | $15.78B | $12.78B | $30.33B | $23.30B | $16.72B | $1.54B | $2.62B | $824M | · | · | |
| Enterprise Value | $10.38B | $11.83B | $15.00B | $12.17B | $29.34B | $22.89B | $16.53B | $1.26B | $2.29B | $747M | · | · | |
| P/E | 25.6 | 360.2 | 150.9 | -34.4 | -140.3 | -177.9 | -156.7 | -20.4 | -91.7 | 67.8 | · | · | |
| P/S | 21.2 | 19.9 | 18.8 | 30.0 | 85.2 | 102.2 | 81.6 | 7.2 | 10.9 | 3.8 | · | · | |
| P/B | 9.4 | 16.5 | 21.6 | 20.9 | 30.7 | 48.1 | 58.1 | 4.0 | 5.7 | 4.5 | · | · | |
| P / Tangible Book | 9.5 | 16.6 | 21.7 | 21.1 | 30.8 | 48.5 | · | · | · | · | · | · | |
| P / Cash Flow | -179.8 | 25271.2 | 72.0 | -47.6 | -148.5 | -375.4 | -206.6 | -46.9 | -292.9 | -86.1 | · | · | |
| P / FCF | -147.6 | -720.3 | 84.5 | -41.9 | -137.5 | -332.8 | -186.9 | -39.3 | -187.6 | -59.3 | · | · | |
| EV / EBITDA | -401.5 | -377.2 | 564.4 | -30.5 | -91.4 | -120.1 | -116.9 | -14.2 | -45.1 | -16.8 | · | · | |
| EV / FCF | -131.7 | -678.5 | 80.4 | -39.9 | -133.0 | -327.0 | -184.7 | -32.3 | -164.1 | -53.8 | · | · | |
| EV / Revenue | 18.9 | 18.8 | 17.9 | 28.5 | 82.4 | 100.4 | 80.7 | 5.9 | 9.5 | 3.5 | · | · | |
| Earnings Yield | 3.9% | 0.28% | 0.66% | -2.9% | -0.71% | -0.56% | -0.64% | -4.9% | -1.1% | 1.5% | · | · |
Per Share
| Metric | Trend | Q4 2019 | Q4 2018 |
|---|---|---|---|
| EPS (TTM) | $-0.16 | $-1.13 |
Valuation (TTM)
| Metric | Trend | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Revenue TTM | $205M | $214M | |
| Net Income TTM | $-106M | $-75M | |
| P/E | -156.7 | -20.4 | |
| Earnings Yield | -0.64% | -4.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $549M | $630M | $838M | $426M | $356M |
| Operating Margin % | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% |
| Net Income | $457M | $38M | $101M | $-361M | $-195M |
| Diluted EPS | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Current Ratio | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-79M | $-17M | $187M | $-305M | $-221M |
Institutional owners (13F) 58 filers · $45.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
58
Value held
$45.7M
New positions
9
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 (+1 vs prior Q) | 4 (-1 vs prior Q) | 14 (+1 vs prior Q) | 23 (+4 vs prior Q) | +134K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15,823,961 | 1,477,494 | 34.65% | Shares |
| Allianz Asset Management GmbH | $7,257,739 | 674,511 | 15.89% | Shares |
| STATE STREET CORP | $3,374,454 | 313,611 | 7.39% | Shares |
| AIA Group Ltd | $3,133,624 | 291,229 | 6.86% | Shares |
| M&G PLC | $2,670,701 | 242,791 | 5.85% | Shares |
| Amundi | $2,199,183 | 204,385 | 4.82% | Shares |
| JANE STREET GROUP, LLC | $2,092,519 | 194,472 | 4.58% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,400,952 | 130,200 | 3.07% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,123,613 | 104,425 | 2.46% | Shares |
| XY Capital Ltd | $1,120,439 | 104,130 | 2.45% | Shares |
| Crossmark Global Holdings, Inc. | $913,685 | 84,915 | 2.00% | Shares |
| TWO SIGMA INVESTMENTS, LP | $680,548 | 63,248 | 1.49% | Shares |
| UBS Group AG | $475,409 | 44,183 | 1.04% | Shares |
| Vanguard Personalized Indexing Management, LLC | $458,365 | 42,599 | 1.00% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $419,285 | 38,967 | 0.92% | Shares |
| CITADEL ADVISORS LLC | $409,536 | 38,061 | 0.90% | Shares |
| Vident Advisory, LLC | $286,044 | 26,584 | 0.63% | Shares |
| MILLENNIUM MANAGEMENT LLC | $284,279 | 26,420 | 0.62% | Shares |
| StoneX Group Inc. | $213,563 | 18,262 | 0.47% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $195,498 | 18,169 | 0.43% | Shares |
| AMERIPRISE FINANCIAL INC | $169,384 | 15,742 | 0.37% | Shares |
| Summit Trail Advisors, LLC | $140,848 | 13,090 | 0.31% | Shares |
| BANK OF AMERICA CORP /DE/ | $134,382 | 12,489 | 0.29% | Shares |
| XTX Topco Ltd | $133,521 | 12,409 | 0.29% | Shares |
| Mariner, LLC | $114,659 | 10,656 | 0.25% | Shares |
| MORGAN STANLEY | $91,944 | 8,545 | 0.20% | Shares |
| Blue Trust, Inc. | $82,938 | 7,708 | 0.18% | Shares |
| ROYAL BANK OF CANADA | $58,000 | 5,428 | 0.13% | Shares |
| Russell Investments Group, Ltd. | $51,633 | 4,821 | 0.11% | Shares |
| RHUMBLINE ADVISERS | $41,755 | 3,881 | 0.09% | Shares |
| FMR LLC | $32,097 | 2,983 | 0.07% | Shares |
| Rockefeller Capital Management L.P. | $11,632 | 1,081 | 0.03% | Shares |
| Bell Investment Advisors, Inc | $10,922 | 1,015 | 0.02% | Shares |
| ASSETMARK, INC | $8,737 | 812 | 0.02% | Shares |
| BlackRock, Inc. | $7,625 | 709 | 0.02% | Shares |
| JPMORGAN CHASE & CO | $6,405 | 598 | 0.01% | Shares |
| Silver Grove Financial Group, Inc. | $6,273 | 583 | 0.01% | Shares |
| US BANCORP \DE\ | $5,950 | 553 | 0.01% | Shares |
| Arax Advisory Partners | $4,304 | 400 | 0.01% | Shares |
| North Star Investment Management Corp. | $4,078 | 379 | 0.01% | Shares |
| SIMPLEX TRADING, LLC | $3,271 | 304 | 0.01% | Shares |
| FIDUCIARY FINANCIAL ADVISORS | $3,110 | 291 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $2,485 | 231 | 0.01% | Shares |
| CITIGROUP INC | $2,055 | 191 | 0.00% | Shares |
| Physician Wealth Advisors, Inc. | $1,550 | 144 | 0.00% | Shares |
| Cornerstone Financial Management LLC | $1,442 | 134 | 0.00% | Shares |
| Pinnacle Wealth Planning Services, Inc. | $1,334 | 124 | 0.00% | Shares |
| EverSource Wealth Advisors, LLC | $990 | 92 | 0.00% | Shares |
| ACADIAN ASSET MANAGEMENT LLC | $696 | 65,166 | 0.00% | Shares |
| Larson Financial Group LLC | $387 | 36 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| HUTCHMED Group Investment Limited (formerly known as “Hutchison China MediTech Investment Limited”), HUTCHMED (China) Limited | Feb. 7, 2022 | · | Initial filing | · | SEC |
| Hutchison China MediTech Investment Limited, HUTCHMED (China) Limited | Aug. 16, 2021 | · | Initial filing | Passive investment | SEC |
| General Atlantic Singapore HCM Pte. Ltd., General Atlantic Singapore Fund Pte. Ltd., General Atlantic Singapore Interholdco Ltd., General Atlantic Partners (Bermuda) IV, L.P., General Atlantic Partners (Bermuda) EU, L.P., General Atlantic Partners (Lux) SCSp, L.P., General Atlantic GenPar (Lux) SCSp, L.P., General Atlantic (Lux) S.à r.l., General Atlantic GenPar (Bermuda), L.P., GAP (Bermuda) Limited, General Atlantic LLC, GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments V, LLC, GAP Coinvestments CDA, L.P. ×2 filings | July 1, 2021 | · | Initial filing | · | SEC |
| Hutchison Healthcare Holdings Limited, Hutchison Whampoa (China) Limited, CK Hutchison Global Investments Limited, CK Hutchison Holdings Limited ×8 filings | June 30, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 4 insiders · 4 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO | May 20, 2026 J | · | 0 | 0 | $0 |
| Wei-Guo Su | CEO and CSO | May 20, 2026 J | · | 0 | 0 | $0 |
| Lorenso Chiu | Deputy Chief Financial Officer | May 20, 2026 J | · | 0 | 0 | $0 |
| Charles George Rupert Nixon | Group General Counsel | May 20, 2026 J | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
HCM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 28 analysts
BUY
Median target
$19.50
+37.3%
10 35.7%
Strong Buy
13 46.4%
Buy
5 17.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
14 analysts · 2026-10-02Mean target $22.01 +55.0%
Now
Current price $14.20
Low$13.60
Mean$22.01
High$40.40
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HCM | $11.63B | 25.6 | · | 83.3% | 45.7% | · |
| RGC | $8.43B | -23.7 | · | · | -54.8% | · |
Latest News Recent headlines mentioning this company
Intuit (INTU) Launches AI-Native QuickBooks Workforce Platform
Yahoo Finance · 3 months, 3 weeks ago
Citi Calls Cytokinetics, Incorporated (CYTK) a “Top Pick” Among Small-to-Mid Cap Biotech Stocks
Yahoo Finance · 4 months ago
Is Paychex, Inc. (PAYX) A Good Stock To Buy Now?
Yahoo Finance · 5 months ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 5, 2026